Skip to content

Effect of intravenous injection of different doses of lidocaine on intracranial pressure in gynecological laparoscopic surgery

Effect of intravenous injection of different doses of lidocaine on intracranial pressure in gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097063
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative intracranial pressure

Interventions

Lidocaine low-dose group (L1 group):Lidocaine 1mg/ (kg·h)
Lidocaine high-dose group (L2 group):Lidocaine 2mg/ (kg·h)

Sponsors

Ningxia Hui Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Gynecological laparoscopic surgery with low head and high foot, including laparoscopic adjunct resection, laparoscopic myomectomy and laparoscopic total hysterectomy; 2) Age 18-60 years old; 3) A body mass index (BMI) of 18-25 kg/m2; 4) American Society of Anesthesiologists ASA grade I ~ II; 5) Have normal cognitive and communication skills.

Exclusion criteria

Exclusion criteria: 1) History of drug allergy to lidocaine; 2) The operation time is less than 1h or more than 3h; 3) Previous history of laparoscopic surgery, ophthalmic surgery or neurosurgery; 4) Combined with a history of eye diseases, such as ocular trauma, optic neuritis, optic nerve tumor, glaucoma, etc. 5) Combined with central nervous system diseases and cerebrovascular diseases, such as motion sickness, craniocerebral trauma, intracranial infection, cerebral infarction, cerebral hemorrhage, brain tumor, etc.; 6) Combined with severe respiratory, circulatory or endocrine system diseases; 7) Recently take drugs that affect cerebrospinal fluid pressure, such as diuretics, glucocorticoids, etc.

Design outcomes

Primary

MeasureTime frame
Optic nerve sheath diameter;

Secondary

MeasureTime frame
Intraoperative vital signs;Recovery time for spontaneous breathing;Awakening time;Extubation time;Recovery room residence time;Riker rating;Postoperative VAS pain score;Three day postoperative complications;Occurrence and extent of adverse reactions related to lidocaine (perioral numbness, bradycardia, hypotension);Use of emergency antiemetic drugs;Use of emergency analgesics;

Countries

China

Contacts

Public ContactZhenhai Ye

Ningxia Hui Autonomous Region People's Hospital

13619506202@163.com+86 136 1950 6202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026